ASPI — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-14

• export controls on helium to maintain domestic supply, further constraining global availability. We believe that the U.S. International Development Finance Corporation (“DFC”) previously indicated its willingness to consider supporting the funding of Phase 2 of the Virginia Gas Project for up to $50…

• ENDRA. On May 27, 2026, we purchased 66,846 shares of ENDRA common stock, 511,541 prefunded warrants to purchase shares of common stock and 1,156,774 common warrants to purchase shares of common stock for a total aggregate purchase price of $3.8 million. ENDRA is the pioneer of Thermo Acoustic Enhan…

• In July 2025, we issued 7,500,000 shares of common stock at $8.00 per share in a registered direct offering resulting in net

• proceeds of approximately $56.3 million after deducting underwriting discounts, commissions and offering expenses.

• On November 19, 2025, QLE received gross proceeds of $72.2 million through the issuance of convertible promissory notes with a stated interest rate of 8% (the “2025 Notes”). The maturity date of the 2025 Notes is November 19, 2030. The 2025 Notes automatically convert into common shares upon QLE’s c…

Text removed vs the prior filing · source: 10-Q · 2026-05-20

• to ensure new helium supply comes online as aerospace and the semiconductor industry increase helium requirements in the face of diminished supply, while increasing South Africa’s domestic energy supply.

• In July 2025, we issued 7,500,000 shares of common stock at $8.00 per share in a registered direct offering resulting in net proceeds of approximately $56.3 million after deducting underwriting discounts, commissions and offering expenses.

• On November 19, 2025, QLE received gross proceeds of $72.2 million through the issuance of convertible promissory notes with a stated interest rate of 8% (the “2025 Notes”). The maturity date of the 2025 Notes is November 19, 2030. The 2025 Notes automatically

• convert into common shares upon QLE’s closing of an IPO or other qualifying public transaction at 80% of the share price taking into consideration a valuation cap. In connection with the issuance of the 2025 Notes, QLE’s outstanding convertible promissory notes originally issued in March 2024 and Ju…

• On January 6, 2026, the Company issued 14,270,000 Consideration Shares in connection with the acquisition of Renergen.

Text added vs the prior filing · source: 10-Q · 2026-08-14

• The Merger is subject to conditions, including approval by ENDRA’s stockholders, that are outside the parties’ control, and the Merger may not be completed.

• The completion of the Merger is subject to the satisfaction or waiver of a number of conditions, many of which are outside the control of the parties. These conditions include, among others, the approval of the ENDRA stockholder matters by ENDRA’s stockholders, the effectiveness of the registration …

• If the Merger is not completed, the Company’s and Renergen’s respective businesses may be adversely affected, and each will be subject to a number of risks, including that the parties will have incurred significant costs that must be paid regardless of whether the Merger is completed and that manage…

• The anticipated benefits of the Merger may not be realized, or may take longer to realize than expected.

• The Company, Noble and ENDRA entered into the Merger Agreement with the expectation that the Merger will result in Noble Africa Inc., including Renergen’s operations (the “Combined Company”), having access to the U.S. public capital markets. However, even if the Merger is completed, there can be no …

Text added vs the prior filing · source: 10-Q · 2026-08-14

• During the six months ended June 30, 2026, the following directors adopted trading arrangements intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act:

• On June 30, 2026, Michael Gorley, a member of the Company’s board of directors, adopted a Rule 10b5-1 trading arrangement for the sale of up to 23,756 shares of the Company's common stock. The trading arrangement is scheduled to expire on December 18, 2026.

• On June 30, 2026, Robert Ryan, a member of the Company’s board of directors, adopted a Rule 10b5-1 trading arrangement for the sale of up to 18,274 shares of the Company's common stock. The trading arrangement is scheduled to expire on December 18, 2026.

• Other than the trading arrangements described above, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of ours adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Text removed vs the prior filing · source: 10-Q · 2026-05-20

• During the three months ended March 31, 2026, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of ours adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.